GlaxoSmith Kline (GSK) required a new pharmacy suite to be commissioned and validated for their clinical investigation unit; the pharmacy suite needed to meet GxP requirements to enable the processing of pharmaceutical product used in clinical trials investigations. Valcomm were commissioned by GSK to validate the pharmacy suite through to successful approval from the Medicens and Healthcare Regulatory Authority (MHRA) approval.